GDTC

CytoMed Therapeutics Ltd

NASDAQ · Biotechnology mkt cap 10,886,208
Company page ›Healthcare ›Biotechnology
High confidence Medium Low Unknown
Line thickness = strength · colour = confidence

Drawing the 24 strongest — 32 further edges are not on this diagram

Relationships 24 of 56

Capped at 24 strongest — 32 not shown

Peer similarity 24

Computed by us from market capitalisation, earnings cadence, dividend frequency and exchange. Not a reported relationship.

VTGN Vistagen Therapeutics, Inc. Graph ›
1.00 conf 1.00
BLRX BioLineRx Ltd. Graph ›
1.00 conf 1.00
KPRX KIORA PHARMACEUTICALS INC Graph ›
1.00 conf 1.00
QNRX Quoin Pharmaceuticals, Ltd. Graph ›
0.99 conf 1.00
TRAW Traws Pharma, Inc. Graph ›
0.99 conf 1.00
PHIO Phio Pharmaceuticals Corp. Graph ›
0.99 conf 1.00
ICU SeaStar Medical Holding Corp Graph ›
0.98 conf 1.00
EVGN Evogene Ltd. Graph ›
0.98 conf 1.00
SNGX SOLIGENIX, INC. Graph ›
0.98 conf 1.00
PASG Passage BIO, Inc. Graph ›
0.98 conf 1.00
HIND Vyome Holdings, Inc Graph ›
0.98 conf 1.00
NRSN NeuroSense Therapeutics Ltd. Graph ›
0.97 conf 1.00
CTXR Citius Pharmaceuticals, Inc. Graph ›
0.97 conf 1.00
TPST Tempest Therapeutics, Inc. Graph ›
0.97 conf 1.00
ACXP Acurx Pharmaceuticals, Inc. Graph ›
0.96 conf 1.00
CMMB Chemomab Therapeutics Ltd. Graph ›
0.96 conf 1.00
PULM Pulmatrix, Inc. Graph ›
0.95 conf 1.00
CVKD Cadrenal Therapeutics, Inc. Graph ›
0.95 conf 1.00
TCRT Alaunos Therapeutics, Inc. Graph ›
0.93 conf 1.00
QNCX Quince Therapeutics, Inc. Graph ›
0.91 conf 1.00
RNAZ Transcode Therapeutics, Inc. Graph ›
0.88 conf 1.00
TLSA Tiziana Life Sciences Ltd Graph ›
0.81 conf 1.00
TOVX Theriva Biologics, Inc. Graph ›
0.80 conf 1.00
APM Aptorum Group Ltd Graph ›
0.77 conf 1.00

Edge strength is relative to the strongest edge in this view and is not comparable across views. Confidence is the mean confidence of the active evidence behind an edge, on an absolute scale. Peer-similarity edges are computed by us and are not a reported relationship; co-mention edges record that two companies appeared in the same article, which is adjacency rather than a business connection.